HCPCS J0585: OnabotulinumtoxinA Injection, 1 Unit
HCPCS Level II code J0585 represents billing for an injection of onabotulinumtoxinA, 1 unit, used for chemodenervation procedures; the service is a therapeutic botulinum toxin injection and the typical site of service is an outpatient clinic or physician office where focal muscle injections are performed.
For related coverage guidance, see recent payer policy updates: Epithelial Cell Cytology in Breast Cancer Risk Assessment, Chemotherapy Observation or Inpatient Hospitalization (for New Mexico Only), Umbilical Cord Blood Harvesting and Storage for Future Use (for Indiana Only).
Customize your policy alerts
Sign up for hcpcs J0585 policy alerts
Get alerted when payer policies referencing J0585 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
National commercial rates for J0585 center on a BUCA average commercial rate of $123.30, with individual commercial carriers clustering below and above that level. Blue Cross Blue Shield shows very tight dispersion (P75–P25 = $0.80), Cigna is similarly constrained (P75–P25 = $1.50), and UnitedHealth Group is narrow as well (P75–P25 = $0.40), indicating consistent contracted pricing among those carriers. Aetna exhibits extreme spread driven by outliers (P75–P25 = $1,351.20), reflecting substantial variability in negotiated highs versus lows across markets.
Mean and median differentials highlight concentration versus skew: Blue Cross Blue Shield, Cigna, and UnitedHealth Group have means near their medians, consistent with symmetric distributions, while Aetna’s mean ($820.60) far exceeds its median ($375.00), signaling a right-skewed distribution. The BUCA mean ($123.30) sits between the tight regional carriers and the high-variance Aetna, representing an average commercial benchmark for comparison.